Abstract
Obtaining the informed consent of a participant is a prerequisite for enrollment in a clinical trial. In the United States, federal regulations provide the framework for establishing informed consent with additional protections for persons considered vulnerable due to incarceration, illiteracy, or other condition. Investigators are tasked with providing sufficient information about the research to satisfy the ethical and regulatory requirements while communicating it in a manner that maximizes the participant’s ability to make an informed decision regarding study enrollment. There are clinical trial design features that are essential to include in the consent form with care to describe topics such as randomization, allocation ratio, and masking in a manner understood by the lay public. The informed consent discussion should continue throughout the course of the trial as informally reaffirming the participant’s willingness to continue participation and reconsenting them when there are significant changes to the study protocol are important considerations for providing truly informed consent.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alzheimer’s Association (2004) Research consent for cognitively impaired adults: recommendations for institutional review boards and investigators. Alzheimer Dis Assoc Disord 18(3):171–175. https://doi.org/10.1097/01.wad.0000137520.23370.56
Casagrande SS, Jerome GJ, Dalcin AT, Dickerson FB, Anderson CA, Appel LJ, Charleston J, Crum RM, Young DR, Guallar E, Frick KD, Goldberg RW, Oefinger M, Finkelstein J, Gennusa JV, Fred-Omojole O, Campbell LM, Wang N-Y, Daumit GL (2010) Randomized trial of achieving health lifestyles in psychiatric rehabilitation: the ACHIEVE trial. BMC Psychiatry 10:108. https://doi.org/10.1186/1471-244X-10-108
Department of Health and Human Services, Office for Human Research Protections (2008) Engagement of institutions in human subjects research. Available at https://www.hhs.gov/ohrp/regulations-and-policy/guidance/guidance-on-engagement-of-institutions/index.html. Accessed 23 June 2020
Department of Health and Human Services, Office for Human Research Protections (n.d.) Protection of Human Subjects 45 CFR §46.116 (a) and (b). Available at https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html. Accessed 23 June 2020
Department of Health and Human Services, US Food and Drug Administration (2014) Informed consent information sheet: guidance for IRBs, clinical investigators, and sponsors. Available at https://www.fda.gov/RegulatoryInformation/Guidances/ucm404975.htm#genrequirments Accessed 23 June 2020
Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, Brough HA, Phippard D, Basting M, Feeney M, Turcanu V, Sever ML, Lorenzo MG, Plaut M, Lack G for the LEAP Study Team (2015) Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med 372:803–813
Ervin AM, Mkocha H, Munoz B, Dreger K, Dize L, Gaydos C, Quinn TC, West SK (2016) Surveillance and azithromycin treatment for newcomers and travelers evaluation (ASANTE) trial: design and baseline characteristics. Ophthalmic Epidemiol 23(6):347–353. https://doi.org/10.1080/09286586.2016.1238947
European Medicines Agency International Conference on Harmonisation Guideline for Good Clinical Practice ICH GCP E6(R2) Step 5. Available at https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e-6-r2-guideline-good-clinical-practice-step-5_en.pdf. Accessed 23 June 2020
Grady C, Toulomi G, Walker AS, Smolskis M, Sharma S, Babiker AG, Pantazis N, Tavel J, Florence E, Sanchez A, Hudson F, Papadopoulos A, Emanuel E, Clewett M, Munroe D, Denning E, The INSIGHT START Informed Consent Substudy Group (2017) A randomized trial comparing concise and standard consent forms in the START trial. PLoS One 12(4):e0172607
Kao CY, Aranda S, Krishnasamy M, Hamilton B (2017) Interventions to improve patient understanding of cancer clinical trial participation: a systematic review. Eur J Cancer Care 26:e124124. https://doi.org/10.1111/ecc.12424
National Institutes of Health, National Heart, Lung, and Blood Institute (2011) Questions and answers: PANTHER-IPF study. Available at https://www.nhlbi.nih.gov/node-general/questions-and-answers-panther-ipf-study. Accessed 23 June 2020
Sisk BA, Kodish E (2018) Therapeutic misperceptions in early-phase cancer trials: from categorical to continuous. IRB Ethics Hum Res 40(4):13–20
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2012) Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 366:1968–1977
The Medicines for Human Use (Clinical Trials) Amendment (No. 2) Regulations (2006). Available at http://www.legislation.gov.uk/uksi/2006/2984/pdfs/uksi_20062984_en.pdf. Accessed 23 June 2020
Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans – TCPS2 (2018). Available at http://www.ethics.gc.ca/eng/policy-politique_tcps2-eptc2_2018.html. Accessed 23 June 2020
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Ervin, AM., Cobb Pettit, J.B. (2020). Consent Forms and Procedures. In: Piantadosi, S., Meinert, C. (eds) Principles and Practice of Clinical Trials. Springer, Cham. https://doi.org/10.1007/978-3-319-52677-5_46-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-52677-5_46-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52677-5
Online ISBN: 978-3-319-52677-5
eBook Packages: Springer Reference MathematicsReference Module Computer Science and Engineering